Charco Neurotech uses stapp one advanced sensor technology to learn more about the movement patterns of people with Parkinson’s, to perform gait analysis and to test their CUE1 using live biofeedback.
Charco Neurotech prepares to relaunch CUE1+ following trial findings and medical device certification. Read article
Read moreResults from a clinical trial of CUE1+, a chest-mounted device, has shown it’s well tolerated by people with…
Read moreA double-blind, placebo-controlled study of 50 people with Parkinson’s, published in Parkinson’s Disease, part of the Nature Portfolio, is the first…
Read more
